← Back to patent-cliff list
CAS 208175-71-7
ethyl 4-(quinoline-8-sulfonamido)benzoate
Codes: MITAP-003
Application context (from source-drug indications)
α-地中海贫血Mitapivat sulfateBeta thalassaemiaMitapivat sulfate丙酮酸激酶缺乏症Mitapivat sulfateHaemolytic anaemiaMitapivat sulfate先天性溶血性贫血Mitapivat sulfateSickle cell diseaseMitapivat sulfate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Mitapivat sulfate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
ethyl 4-aminobenzoate→quinoline-8-sulfonyl chloride→ethyl 4-(quinoline-8-sulfonamido)benzoate→4-(quinoline-8-sulfonamido)benzoic acid→tert-butyl piperazine-1-carboxylate→tert-butyl 4-(4-(quinoline-8-sulfonamido)benzoyl)piperazine-1-carboxylate→N-(4-(piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide→cyclopropanecarbaldehyde→Mitapivat
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.